Interdisciplinary approach to iridium (iv) oxide (IrO2) nanoparticles as weapons against cancer under synchrotron and synchrocyclotron radiations

Authors

  • Alireza Heidari Faculty of Chemistry, California South University (CSU), Irvine, California, USA
  • Margaret Hotz
  • Nancy MacDonald
  • Victoria Peterson
  • Angela Caissutti
  • Elizabeth Besana
  • Jennifer Esposito
  • Katrina Schmitt
  • Ling-Yu Chan
  • Francesca Sherwood
  • Maria Henderson
  • Jimmy Kimmel

DOI:

https://doi.org/10.14419/ijac.v9i2.31658

Keywords:

Iridium (IV) Oxide (IrO2) Nanoparticles, Weapons, Cancer, Synchrotron and Synchrocyclotron Radiations.

Abstract

In the current research, interdisciplinary approach to Iridium (IV) Oxide (IrO2) nanoparticles as weapons against cancer under synchrotron and synchrocyclotron radiations is investigated. The calculation of thickness and optical constants of Iridium (IV) Oxide (IrO2) interdisciplinary approach to Iridium (IV) Oxide (IrO2) nanoparticles as weapons against cancer under synchrotron and synchrocyclotron radiations produced using sol–gel method over glassy medium through a single reflection spectrum is presented. To obtain an appropriate fit for reflection spectrum, the classic Drude–Lorentz model for parametric di–electric function is used. The best fitting parameters are determined to simulate the reflection spectrum using Lovenberg–Marquardt optimization method. The simulated reflectivity from the derived optical constants and thickness are in good agreement with experimental results.

 

  

 

Interdisciplinary Approach to Iridium (IV) Oxide (IrO2) Nanoparticles as Weapons Against Cancer Under Synchrotron and Synchrocyclotron Radiations.

 

 

 

 

 

 

 

References

[1] A. Heidari, C. Brown, “Study of Composition and Morphology of Cadmium Oxide (CdO) Nanoparticles for Eliminating Cancer Cellsâ€, J Nanomed Res., Volume 2, Issue 5, 20 Pages, 2015.

[2] A. Heidari, C. Brown, “Study of Surface Morphological, Phytochemical and Structural Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticlesâ€, International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume 1, Issue 1, Pages 15–19, 2015.

[3] A. Heidari, “An Experimental Biospectroscopic Study on Seminal Plasma in Determination of Semen Quality for Evaluation of Male Infertilityâ€, Int J Adv Technol 7: e007, 2016.

[4] A. Heidari, “Extraction and Preconcentration of N–Tolyl–Sulfonyl–Phosphoramid–Saeure–Dichlorid as an Anti–Cancer Drug from Plants: A Pharmacognosy Studyâ€, J Pharmacogn Nat Prod 2: e103, 2016.

[5] A. Heidari, “A Thermodynamic Study on Hydration and Dehydration of DNA and RNA−Amphiphile Complexesâ€, J Bioeng Biomed Sci S: 006, 2016.

[6] A. Heidari, “Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=Oâ€, J Appl Computat Math 5: e142, 2016.

[7] A. Heidari, “Study of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopiesâ€, J Biomol Res Ther 5: e146, 2016.

[8] A. Heidari, “Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cellsâ€, J Bioanal Biomed 8: e135, 2016.

[9] A. Heidari, “A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cellsâ€, Adv Cancer Prev 1: e102, 2016.

[10] A. Heidari, “Manufacturing Process of Solar Cells Using Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticlesâ€, J Biotechnol Biomater 6: e125, 2016.

[11] A. Heidari, “A Novel Experimental and Computational Approach to Photobiosimulation of Telomeric DNA/RNA: A Biospectroscopic and Photobiological Studyâ€, J Res Development 4: 144, 2016.

[12] A. Heidari, “Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin Bindingâ€, Biochem Physiol 5: e146, 2016.

[13] A. Heidari, “Anti–Cancer Effect of UV Irradiation at Presence of Cadmium Oxide (CdO) Nanoparticles on DNA of Cancer Cells: A Photodynamic Therapy Studyâ€, Arch Cancer Res. 4: 1, 2016.

[14] A. Heidari, “Biospectroscopic Study on Multi–Component Reactions (MCRs) in Two A–Type and B–Type Conformations of Nucleic Acids to Determine Ligand Binding Modes, Binding Constant and Stability of Nucleic Acids in Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes as Anti–Cancer Drugsâ€, Arch Cancer Res. 4: 2, 2016.

[15] A. Heidari, “Simulation of Temperature Distribution of DNA/RNA of Human Cancer Cells Using Time–Dependent Bio–Heat Equation and Nd: YAG Lasersâ€, Arch Cancer Res. 4: 2, 2016.

[16] A. Heidari, “Quantitative Structure–Activity Relationship (QSAR) Approximation for Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation Approachâ€, Ann Clin Lab Res. 4: 1, 2016.

[17] A. Heidari, “Biomedical Study of Cancer Cells DNA Therapy Using Laser Irradiations at Presence of Intelligent Nanoparticlesâ€, J Biomedical Sci. 5: 2, 2016.

[18] A. Heidari, “Measurement the Amount of Vitamin D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol) and Absorbable Calcium (Ca2+), Iron (II) (Fe2+), Magnesium (Mg2+), Phosphate (PO4–) and Zinc (Zn2+) in Apricot Using High–Performance Liquid Chromatography (HPLC) and Spectroscopic Techniquesâ€, J Biom Biostat 7: 292, 2016.

[19] A. Heidari, “Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cationsâ€, Chem Sci J 7: e112, 2016.

[20] A. Heidari, “Human Toxicity Photodynamic Therapy Studies on DNA/RNA Complexes as a Promising New Sensitizer for the Treatment of Malignant Tumors Using Bio–Spectroscopic Techniquesâ€, J Drug Metab Toxicol 7: e129, 2016.

[21] A. Heidari, “Novel and Stable Modifications of Intelligent Cadmium Oxide (CdO) Nanoparticles as Anti–Cancer Drug in Formation of Nucleic Acids Complexes for Human Cancer Cells’ Treatmentâ€, Biochem Pharmacol (Los Angel) 5: 207, 2016.

[22] A. Heidari, “A Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) as Hydrogen Storageâ€, Struct Chem Crystallogr Commun 2: 1, 2016.

[23] A. Heidari, “Pharmaceutical and Analytical Chemistry Study of Cadmium Oxide (CdO) Nanoparticles Synthesis Methods and Properties as Anti–Cancer Drug and its Effect on Human Cancer Cellsâ€, Pharm Anal Chem Open Access 2: 113, 2016.

[24] A. Heidari, “A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double–Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatmentâ€, Chemo Open Access 5: e129, 2016.

[25] A. Heidari, “Pharmacokinetics and Experimental Therapeutic Study of DNA and Other Biomolecules Using Lasers: Advantages and Applicationsâ€, J Pharmacokinet Exp Ther 1: e005, 2016.

[26] A. Heidari, “Determination of Ratio and Stability Constant of DNA/RNA in Human Cancer Cells and Cadmium Oxide (CdO) Nanoparticles Complexes Using Analytical Electrochemical and Spectroscopic Techniquesâ€, Insights Anal Electrochem 2: 1, 2016.

[27] A. Heidari, “Discriminate between Antibacterial and Non–Antibacterial Drugs Artificial Neutral Networks of a Multilayer Perceptron (MLP) Type Using a Set of Topological Descriptorsâ€, J Heavy Met Toxicity Dis. 1: 2, 2016.

[28] A. Heidari, “Combined Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius Rearrangement for Synthesis of Mechlorethamine, Cisplatin, Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer Drugsâ€, Insights Med Phys. 1: 2, 2016.

[29] A. Heidari, “A Translational Biomedical Approach to Structural Arrangement of Amino Acids’ Complexes: A Combined Theoretical and Computational Studyâ€, Transl Biomed. 7: 2, 2016.

[30] A. Heidari, “Ab Initio and Density Functional Theory (DFT) Studies of Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO) Nanoparticles Complexes in Human Cancer Cellsâ€, J Nanomedine Biotherapeutic Discov 6: e144, 2016.

[31] A. Heidari, “Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Studyâ€, J Glycobiol 5: e111, 2016.

[32] A. Heidari, “Synthesis and Study of 5–[(Phenylsulfonyl)Amino]–1,3,4–Thiadiazole–2–Sulfonamide as Potential Anti–Pertussis Drug Using Chromatography and Spectroscopy Techniquesâ€, Transl Med (Sunnyvale) 6: e138, 2016.

[33] A. Heidari, “Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equationsâ€, Electronic J Biol 12: 4, 2016.

[34] A. Heidari, “An Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes in Nucleic Acidsâ€, Austin J Anal Pharm Chem. 3 (1): 1058, 2016.

[35] A. Heidari, C. Brown, “Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC Nanocompositesâ€, Nano Res Appl. 2: 1, 2016.

[36] A. Heidari, C. Brown, “Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumeneâ€, International Journal of Advanced Chemistry, 4 (1) 5–9, 2016.

[37] A. Heidari, “Study of the Role of Anti–Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissuesâ€, Arch Can Res. 4: 2, 2016.

[38] A. Heidari, “Genomics and Proteomics Studies of Zolpidem, Necopidem, Alpidem, Saripidem, Miroprofen, Zolimidine, Olprinone and Abafungin as Anti–Tumor, Peptide Antibiotics, Antiviral and Central Nervous System (CNS) Drugsâ€, J Data Mining Genomics & Proteomics 7: e125, 2016.

[39] A. Heidari, “Pharmacogenomics and Pharmacoproteomics Studies of Phosphodiesterase–5 (PDE5) Inhibitors and Paclitaxel Albumin–Stabilized Nanoparticles as Sandwiched Anti–Cancer Nano Drugs between Two DNA/RNA Molecules of Human Cancer Cellsâ€, J Pharmacogenomics Pharmacoproteomics 7: e153, 2016.

[40] A. Heidari, “Biotranslational Medical and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–DNA/RNA Straight and Cycle Chain Complexes as Potent Anti–Viral, Anti–Tumor and Anti–Microbial Drugs: A Clinical Approachâ€, Transl Biomed. 7: 2, 2016.

[41] A. Heidari, “A Comparative Study on Simultaneous Determination and Separation of Adsorbed Cadmium Oxide (CdO) Nanoparticles on DNA/RNA of Human Cancer Cells Using Biospectroscopic Techniques and Dielectrophoresis (DEP) Methodâ€, Arch Can Res. 4: 2, 2016.

[42] A. Heidari, “Cheminformatics and System Chemistry of Cisplatin, Carboplatin, Nedaplatin, Oxaliplatin, Heptaplatin and Lobaplatin as Anti–Cancer Nano Drugs: A Combined Computational and Experimental Studyâ€, J Inform Data Min 1: 3, 2016.

[43] A. Heidari, “Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship (QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2) Nanoparticles as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Anti–Cancer Nano Drugsâ€, J Integr Oncol 5: e110, 2016.

[44] A. Heidari, “Synthesis, Characterization and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes Absence of Soluble Polymer as a Protective Agent Using Nucleic Acids Condensation and Solution Reduction Methodâ€, J Nanosci Curr Res 1: e101, 2016.

[45] A. Heidari, “Coplanarity and Collinearity of 4’–Dinonyl–2,2’–Bithiazole in One Domain of Bleomycin and Pingyangmycin to be Responsible for Binding of Cadmium Oxide (CdO) Nanoparticles to DNA/RNA Bidentate Ligands as Anti–Tumor Nano Drugâ€, Int J Drug Dev & Res 8: 007–008, 2016.

[46] A. Heidari, “A Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for the Prediction of Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiationsâ€, J Pharmacovigil 4: e161, 2016.

[47] A. Heidari, “Nanotechnology in Preparation of Semipermeable Polymersâ€, J Adv Chem Eng 6: 157, 2016.

[48] A. Heidari, “A Gastrointestinal Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for Analysis 5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under Synchrotron Radiationsâ€, J Gastrointest Dig Syst 6: e119, 2016.

[49] A. Heidari, “DNA/RNA Fragmentation and Cytolysis in Human Cancer Cells Treated with Diphthamide Nano Particles Derivativesâ€, Biomedical Data Mining 5: e102, 2016.

[50] A. Heidari, “A Successful Strategy for the Prediction of Solubility in the Construction of Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Using Genetic Function Approximation (GFA) Algorithmâ€, J Mol Biol Biotechnol 1: 1, 2016.

[51] A. Heidari, “Computational Study on Molecular Structures of C20, C60, C240, C540, C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations Using Fuzzy Logicâ€, J Material Sci Eng 5: 282, 2016.

[52] A. Heidari, “Graph Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide Hydrochloride (PHMB) Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs)â€, J Appl Computat Math 5: e143, 2016.

[53] A. Heidari, “The Impact of High Resolution Imaging on Diagnosisâ€, Int J Clin Med Imaging 3: 1000e101, 2016.

[54] A. Heidari, “A Comparative Study of Conformational Behavior of Isotretinoin (13–Cis Retinoic Acid) and Tretinoin (All–Trans Retinoic Acid (ATRA)) Nano Particles as Anti–Cancer Nano Drugs under Synchrotron Radiations Using Hartree–Fock (HF) and Density Functional Theory (DFT) Methodsâ€, Insights in Biomed 1: 2, 2016.

[55] A. Heidari, “Advances in Logic, Operations and Computational Mathematicsâ€, J Appl Computat Math 5: 5, 2016.

[56] A. Heidari, “Mathematical Equations in Predicting Physical Behaviorâ€, J Appl Computat Math 5: 5, 2016.

[57] A. Heidari, “Chemotherapy a Last Resort for Cancer Treatmentâ€, Chemo Open Access 5: 4, 2016.

[58] A. Heidari, “Separation and Pre–Concentration of Metal Cations–DNA/RNA Chelates Using Molecular Beam Mass Spectrometry with Tunable Vacuum Ultraviolet (VUV) Synchrotron Radiation and Various Analytical Methodsâ€, Mass Spectrom Purif Tech 2: e101, 2016.

[59] A. Heidari, “Yoctosecond Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Studies for Prediction of Solubility of Anti–Cancer Nano Drugs in Aqueous Solutions Using Genetic Function Approximation (GFA) Algorithmâ€, Insight Pharm Res. 1: 1, 2016.

[60] A. Heidari, “Cancer Risk Prediction and Assessment in Human Cells under Synchrotron Radiations Using Quantitative Structure Activity Relationship (QSAR) and Quantitative Structure Properties Relationship (QSPR) Studiesâ€, Int J Clin Med Imaging 3: 516, 2016.

[61] A. Heidari, “A Novel Approach to Biologyâ€, Electronic J Biol 12: 4, 2016.

[62] A. Heidari, “Innovative Biomedical Equipment’s for Diagnosis and Treatmentâ€, J Bioengineer & Biomedical Sci 6: 2, 2016.

[63] A. Heidari, “Integrating Precision Cancer Medicine into Healthcare, Medicare Reimbursement Changes and the Practice of Oncology: Trends in Oncology Medicine and Practicesâ€, J Oncol Med & Pract 1: 2, 2016.

[64] A. Heidari, “Promoting Convergence in Biomedical and Biomaterials Sciences and Silk Proteins for Biomedical and Biomaterials Applications: An Introduction to Materials in Medicine and Bioengineering Perspectivesâ€, J Bioengineer & Biomedical Sci 6: 3, 2016.

[65] A. Heidari, “X–Ray Fluorescence and X–Ray Diffraction Analysis on Discrete Element Modeling of Nano Powder Metallurgy Processes in Optimal Container
Designâ€
, J Powder Metall Min 6: 1, 2017.

[66] A. Heidari, “Biomolecular Spectroscopy and Dynamics of Nano–Sized Molecules and Clusters as Cross–Linking–Induced Anti–Cancer and Immune–Oncology Nano Drugs Delivery in DNA/RNA of Human Cancer Cells’ Membranes under Synchrotron Radiations: A Payload–Based Perspectiveâ€, Arch Chem Res. 1: 2, 2017.

[67] A. Heidari, “Deficiencies in Repair of Double–Standard DNA/RNA–Binding Molecules Identified in Many Types of Solid and Liquid Tumors Oncology in Human Body for Advancing Cancer Immunotherapy Using Computer Simulations and Data Analysis: Number of Mutations in a Synchronous Tumor Varies by Age and Type of Synchronous Cancerâ€, J Appl Bioinforma Comput Biol, 6: 1, 2017.

[68] A. Heidari, “Electronic Coupling among the Five Nanomolecules Shuts Down Quantum Tunneling in the Presence and Absence of an Applied Magnetic Field for Indication of the Dimer or other Provide Different Influences on the Magnetic Behavior of Single Molecular Magnets (SMMs) as Qubits for Quantum Computingâ€, Glob J Res Rev. 4: 2, 2017.

[69] A. Heidari, “Polymorphism in Nano–Sized Graphene Ligand–Induced Transformation of Au38–xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) Nanomolecules for Synthesis of Au144–xAgx/xCux[(SR)60, (SC4)60, (SC6)60, (SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60 and (SC6H13)60] Nano Clusters as Anti–Cancer Nano Drugsâ€, J Nanomater Mol Nanotechnol, 6: 3, 2017.

[70] A. Heidari, “Biomedical Resource Oncology and Data Mining to Enable Resource Discovery in Medical, Medicinal, Clinical, Pharmaceutical, Chemical and Translational Research and Their Applications in Cancer Researchâ€, Int J Biomed Data Min 6: e103, 2017.

[71] A. Heidari, “Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent for Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy under Synchrotorn Radiationâ€, J Dev Drugs 6: e154, 2017.

[72] A. Heidari, “A Novel Approach to Future Horizon of Top Seven Biomedical Research Topics to Watch in 2017: Alzheimer's, Ebola, Hypersomnia, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Microbiome/Antibiotic Resistance and Endovascular Strokeâ€, J Bioengineer & Biomedical Sci 7: e127, 2017.

[73] A. Heidari, “Opinion on Computational Fluid Dynamics (CFD) Techniqueâ€, Fluid Mech Open Acc 4: 157, 2017.

[74] A. Heidari, “Concurrent Diagnosis of Oncology Influence Outcomes in Emergency General Surgery for Colorectal Cancer and Multiple Sclerosis (MS) Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84, Au329–xAgx(SR)84, Au144(SR)60, Au68(SR)36, Au30(SR)18, Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 andAu25(pMBA)18 Nano Clustersâ€, J Surgery Emerg Med 1: 21, 2017.

[75] A. Heidari, “Developmental Cell Biology in Adult Stem Cells Death and Autophagy to Trigger a Preventive Allergic Reaction to Common Airborne Allergens under Synchrotron Radiation Using Nanotechnology for Therapeutic Goals in Particular Allergy Shots (Immunotherapy)â€, Cell Biol (Henderson, NV) 6: 1, 2017.

[76] A. Heidari, “Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma, Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s Sarcoma, Fibrosarcoma and Secondary Hematopoietic Solid or Soft Tissue Tumorsâ€, J Powder Metall Min 6: 170, 2017.

[77] A. Heidari, “Nanomedicine–Based Combination Anti–Cancer Therapy between Nucleic Acids and Anti–Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatment of Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti–Cancer Nano Drugs and Nucleic Acids Delivery under Synchrotron Radiationâ€, Am J Drug Deliv 5: 2, 2017.

[78] A. Heidari, “Clinical Trials of Dendritic Cell Therapies for Cancer Exposing Vulnerabilities in Human Cancer Cells’ Metabolism and Metabolomics: New Discoveries, Unique Features Inform New Therapeutic Opportunities, Biotech's Bumpy Road to the Market and Elucidating the Biochemical Programs that Support Cancer Initiation and Progressionâ€, J Biol Med Science 1: e103, 2017.

[79] A. Heidari, “The Design Graphene–Based Nanosheets as a New Nanomaterial in Anti–Cancer Therapy and Delivery of Chemotherapeutics and Biological Nano Drugs for Liposomal Anti–Cancer Nano Drugs and Gene Deliveryâ€, Br Biomed Bull 5: 305, 2017.

[80] A. Heidari, “Integrative Approach to Biological Networks for Emerging Roles of Proteomics, Genomics and Transcriptomics in the Discovery and Validation of Human Colorectal Cancer Biomarkers from DNA/RNA Sequencing Data under Synchrotron Radiationâ€, Transcriptomics 5: e117, 2017.

[81] A. Heidari, “Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins and Cell Adhesion Intelligent Nanomolecules Adjustment in Cancer Metastases Using Metalloenzymes and under Synchrotron Radiationâ€, Lett Health Biol Sci 2 (2): 1–4, 2017.

[82] A. Heidari, “Treatment of Breast Cancer Brain Metastases through a Targeted Nanomolecule Drug Delivery System Based on Dopamine Functionalized Multi–Wall Carbon Nanotubes (MWCNTs) Coated with Nano Graphene Oxide (GO) and Protonated Polyaniline (PANI) in Situ During the Polymerization of Aniline Autogenic Nanoparticles for the Delivery of Anti–Cancer Nano Drugs under Synchrotron Radiationâ€, Br J Res, 4 (3): 16, 2017.

[83] A. Heidari, “Sedative, Analgesic and Ultrasound–Mediated Gastrointestinal Nano Drugs Delivery for Gastrointestinal Endoscopic Procedure, Nano Drug–Induced Gastrointestinal Disorders and Nano Drug Treatment of Gastric Acidityâ€, Res Rep Gastroenterol, 1: 1, 2017.

[84] A. Heidari, “Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Orphan Nano Drugs to Treat High Cholesterol and Related Conditions and to Prevent Cardiovascular Disease under Synchrotron Radiationâ€, J Pharm Sci Emerg Drugs 5: 1, 2017.

[85] A. Heidari, “Non–Linear Compact Proton Synchrotrons to Improve Human Cancer Cells and Tissues Treatments and Diagnostics through Particle Therapy Accelerators with Monochromatic Microbeamsâ€, J Cell Biol Mol Sci 2 (1): 1–5, 2017.

[86] A. Heidari, “Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood–Brain Barrier (BBB) Translocation to Targeted Deliver Anti–Cancer Nano Drugs into the Human Brain to Treat Alzheimer’s Disease under Synchrotron Radiationâ€, J Nanotechnol Material Sci 4 (2): 1–5, 2017.

[87] R. Gobato, A. Heidari, “Calculations Using Quantum Chemistry for Inorganic Molecule Simulation BeLi2SeSiâ€, Science Journal of Analytical Chemistry, Vol. 5, No. 6, Pages 76–85, 2017.

[88] A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Lung Cancer Translational Anti–Cancer Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiationsâ€, J Med Oncol. Vol. 1 No. 1: 1, 2017.

[89] A. Heidari, “A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiationâ€, Am J Ethnomed, Vol. 4 No. 1: 10, 2017.

[90] A. Heidari, “Active Targeted Nanoparticles for Anti–Cancer Nano Drugs Delivery across the Blood–Brain Barrier for Human Brain Cancer Treatment, Multiple Sclerosis (MS) and Alzheimer's Diseases Using Chemical Modifications of Anti–Cancer Nano Drugs or Drug–Nanoparticles through Zika Virus (ZIKV) Nanocarriers under Synchrotron Radiationâ€, J Med Chem Toxicol, 2 (3): 1–5, 2017.

[91] A. Heidari, “Investigation of Medical, Medicinal, Clinical and Pharmaceutical Applications of Estradiol, Mestranol (Norlutin), Norethindrone (NET), Norethisterone Acetate (NETA), Norethisterone Enanthate (NETE) and Testosterone Nanoparticles as Biological Imaging, Cell Labeling, Anti–Microbial Agents and Anti–Cancer Nano Drugs in Nanomedicines Based Drug Delivery Systems for Anti–Cancer Targeting and Treatmentâ€, Parana Journal of Science and Education (PJSE)–v.3, n.4, (10–19) October 12, 2017.

[92] A. Heidari, “A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatmentâ€, Open J Anal Bioanal Chem 1 (1): 014–020, 2017.

[93] A. Heidari, “Combination of DNA/RNA Ligands and Linear/Non–Linear Visible–Synchrotron Radiation–Driven N–Doped Ordered Mesoporous Cadmium Oxide (CdO) Nanoparticles Photocatalysts Channels Resulted in an Interesting Synergistic Effect Enhancing Catalytic Anti–Cancer Activityâ€, Enz Eng 6: 1, 2017.

[94] A. Heidari, “Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS)â€, Mod Appro Drug Des. 1 (1). MADD.000504. 2017.

[95] A. Heidari, “Potency of Human Interferon β–1a and Human Interferon β–1b in Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy of Encephalomyelitis Disseminate/Multiple Sclerosis (MS) and Hepatitis A, B, C, D, E, F and G Virus Enter and Targets Liver Cellsâ€, J Proteomics Enzymol 6: 1, 2017.

[96] A. Heidari, “Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti–Cancer Nanodrugs Delivery across the Blood–Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiationâ€, J Pharm Pharmaceutics 4 (2): 1–5, 2017.

[97] A. Heidari, C. Brown, “Combinatorial Therapeutic Approaches to DNA/RNA and Benzylpenicillin (Penicillin G), Fluoxetine Hydrochloride (Prozac and Sarafem), Propofol (Diprivan), Acetylsalicylic Acid (ASA) (Aspirin), Naproxen Sodium (Aleve and Naprosyn) and Dextromethamphetamine Nanocapsules with Surface Conjugated DNA/RNA to Targeted Nano Drugs for Enhanced Anti–Cancer Efficacy and Targeted Cancer Therapy Using Nano Drugs Delivery Systemsâ€, Ann Adv Chem. 1 (2): 061–069, 2017.

[98] A. Heidari, “High–Resolution Simulations of Human Brain Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron Radiationâ€, J Transl Res. 1 (1): 1–3, 2017.

[99] A. Heidari, “Investigation of Anti–Cancer Nano Drugs’ Effects’ Trend on Human Pancreas Cancer Cells and Tissues Prevention, Diagnosis and Treatment Process under Synchrotron and X–Ray Radiations with the Passage of Time Using Mathematicaâ€, Current Trends Anal Bioanal Chem, 1 (1): 36–41, 2017.

[100] A. Heidari, “Pros and Cons Controversy on Molecular Imaging and Dynamics of Double–Standard DNA/RNA of Human Preserving Stem Cells–Binding Nano Molecules with Androgens/Anabolic Steroids (AAS) or Testosterone Derivatives through Tracking of Helium–4 Nucleus (Alpha Particle) Using Synchrotron Radiationâ€, Arch Biotechnol Biomed. 1 (1): 067–0100, 2017.

[101] A. Heidari, “Visualizing Metabolic Changes in Probing Human Cancer Cells and Tissues Metabolism Using Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy and Self–Organizing Maps under Synchrotron Radiationâ€, SOJ Mater Sci Eng 5 (2): 1–6, 2017.

[102] A. Heidari, “Cavity Ring–Down Spectroscopy (CRDS), Circular Dichroism Spectroscopy, Cold Vapour Atomic Fluorescence Spectroscopy and Correlation Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Enliven: Challenges Cancer Detect Ther 4 (2): e001, 2017.

[103] A. Heidari, “Laser Spectroscopy, Laser–Induced Breakdown Spectroscopy and Laser–Induced Plasma Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Int J Hepatol Gastroenterol, 3 (4): 079–084, 2017.

[104] A. Heidari, “Time–Resolved Spectroscopy and Time–Stretch Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Enliven: Pharmacovigilance and Drug Safety 4 (2): e001, 2017.

[105] A. Heidari, “Overview of the Role of Vitamins in Reducing Negative Effect of Decapeptyl (Triptorelin Acetate or Pamoate Salts) on Prostate Cancer Cells and Tissues in Prostate Cancer Treatment Process through Transformation of Malignant Prostate Tumors into Benign Prostate Tumors under Synchrotron Radiationâ€, Open J Anal Bioanal Chem 1 (1): 021–026, 2017.

[106] A. Heidari, “Electron Phenomenological Spectroscopy, Electron Paramagnetic Resonance (EPR) Spectroscopy and Electron Spin Resonance (ESR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Austin J Anal Pharm Chem. 4 (3): 1091, 2017.

[107] A. Heidari, “Therapeutic Nanomedicine Different High–Resolution Experimental Images and Computational Simulations for Human Brain Cancer Cells and Tissues Using Nanocarriers Deliver DNA/RNA to Brain Tumors under Synchrotron Radiation with the Passage of Time Using Mathematica and MATLABâ€, Madridge J Nano Tech. Sci. 2 (2): 77–83, 2017.

[108] A. Heidari, “A Consensus and Prospective Study on Restoring Cadmium Oxide (CdO) Nanoparticles Sensitivity in Recurrent Ovarian Cancer by Extending the Cadmium Oxide (CdO) Nanoparticles–Free Interval Using Synchrotron Radiation Therapy as Antibody–Drug Conjugate for the Treatment of Limited–Stage Small Cell Diverse Epithelial Cancersâ€, Cancer Clin Res Rep, 1: 2, e001, 2017.

[109] A. Heidari, “A Novel and Modern Experimental Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White Synchrotron Radiationâ€, Cancer Sci Res Open Access 4 (2): 1–8, 2017.

[110] A. Heidari, “Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Breast Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiationsâ€, J Oral Cancer Res 1 (1): 12–17, 2017.

[111] A. Heidari, “Vibrational Decihertz (dHz), Centihertz (cHz), Millihertz (mHz), Microhertz (μHz), Nanohertz (nHz), Picohertz (pHz), Femtohertz (fHz), Attohertz (aHz), Zeptohertz (zHz) and Yoctohertz (yHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, International Journal of Biomedicine, 7 (4), 335–340, 2017.

[112] A. Heidari, “Force Spectroscopy and Fluorescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, EC Cancer, 2 (5), 239–246, 2017.

[113] A. Heidari, “Photoacoustic Spectroscopy, Photoemission Spectroscopy and Photothermal Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, BAOJ Cancer Res Ther, 3: 3, 045–052, 2017.

[114] A. Heidari, “J–Spectroscopy, Exchange Spectroscopy (EXSY), Nucle­ar Overhauser Effect Spectroscopy (NOESY) and Total Correlation Spectroscopy (TOCSY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, EMS Eng Sci J, 1 (2): 006–013, 2017.

[115] A. Heidari, “Neutron Spin Echo Spectroscopy and Spin Noise Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Int J Biopharm Sci, 1: 103–107, 2017.

[116] A. Heidari, “Vibrational Decahertz (daHz), Hectohertz (hHz), Kilohertz (kHz), Megahertz (MHz), Gigahertz (GHz), Terahertz (THz), Petahertz (PHz), Exahertz (EHz), Zettahertz (ZHz) and Yottahertz (YHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Madridge J Anal Sci Instrum, 2 (1): 41–46, 2017.

[117] A. Heidari, “Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy and Non–Linear Two–Dimensional Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Timeâ€, J Mater Sci Nanotechnol 6 (1): 101, 2018.

[118] A. Heidari, “Fourier Transform Infrared (FTIR) Spectroscopy, Near–Infrared Spectroscopy (NIRS) and Mid–Infrared Spectroscopy (MIRS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Timeâ€, Int J Nanotechnol Nanomed, Volume 3, Issue 1, Pages 1–6, 2018.

[119] A. Heidari, “Infrared Photo Dissociation Spectroscopy and Infrared Correlation Table Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Timeâ€, Austin Pharmacol Pharm, 3 (1): 1011, 2018.

[120] A. Heidari, “Novel and Transcendental Prevention, Diagnosis and Treatment Strategies for Investigation of Interaction among Human Blood Cancer Cells, Tissues, Tumors and Metastases with Synchrotron Radiation under Anti–Cancer Nano Drugs Delivery Efficacy Using MATLAB Modeling and Simulationâ€, Madridge J Nov Drug Res, 1 (1): 18–24, 2017.

[121] A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Open Access J Trans Med Res, 2 (1): 00026–00032, 2018.

[122] M. R. R. Gobato, R. Gobato, A. Heidari, “Planting of Jaboticaba Trees for Landscape Repair of Degraded Areaâ€, Landscape Architecture and Regional Planning, Vol. 3, No. 1, Pages 1–9, 2018.

[123] A. Heidari, “Fluorescence Spectroscopy, Phosphorescence Spectroscopy and Luminescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Timeâ€, SM J Clin. Med. Imaging, 4 (1): 1018, 2018.

[124] A. Heidari, “Nuclear Inelastic Scattering Spectroscopy (NISS) and Nuclear Inelastic Absorption Spectroscopy (NIAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Int J Pharm Sci, 2 (1): 1–14, 2018.

[125] A. Heidari, “X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, J Oncol Res; 2 (1): 1–14, 2018.

[126] A. Heidari, “Correlation Two–Dimensional Nuclear Magnetic Reso­nance (NMR) (2D–NMR) (COSY) Imaging and Spectrosco­py Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, EMS Can Sci, 1–1–001, 2018.

[127] A. Heidari, “Thermal Spectroscopy, Photothermal Spectroscopy, Thermal Microspectroscopy, Photothermal Microspectroscopy, Thermal Macrospectroscopy and Photothermal Macrospectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, SM J Biometrics Biostat, 3 (1): 1024, 2018.

[128] A. Heidari, “A Modern and Comprehensive Experimental Biospectroscopic Comparative Study on Human Common Cancers’ Cells, Tissues and Tumors before and after Synchrotron Radiation Therapyâ€, Open Acc J Oncol Med. 1 (1), 2018.

[129] A. Heidari, “Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Endocrinology and Thyroid Cancer Cells and Tissues under Synchrotron Radiationâ€, J Endocrinol Thyroid Res, 3 (1): 555603, 2018.

[130] A. Heidari, “Nuclear Resonance Vibrational Spectroscopy (NRVS), Nuclear Inelastic Scattering Spectroscopy (NISS), Nuclear Inelastic Absorption Spectroscopy (NIAS) and Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Int J Bioorg Chem Mol Biol. 6 (1e): 1–5, 2018.

[131] A. Heidari, “A Novel and Modern Experimental Approach to Vibrational Circular Dichroism Spectroscopy and Video Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White and Monochromatic Synchrotron Radiationâ€, Glob J Endocrinol Metab. 1 (3). GJEM. 000514–000519, 2018.

[132] A. Heidari, “Pros and Cons Controversy on Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, EMS Pharma J. 1 (1): 002–008, 2018.

[133] A. Heidari, “A Modern Comparative and Comprehensive Experimental Biospectroscopic Study on Different Types of Infrared Spectroscopy of Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, J Analyt Molecul Tech. 3 (1): 8, 2018.

[134] A. Heidari, “Investigation of Cancer Types Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Studyâ€, European Modern Studies Journal, Vol. 2, No. 1, 13–29, 2018.

[135] A. Heidari, “Saturated Spectroscopy and Unsaturated Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Imaging J Clin Medical Sci. 5 (1): 001–007, 2018.

[136] A. Heidari, “Small–Angle Neutron Scattering (SANS) and Wide–Angle X–Ray Diffraction (WAXD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Int J Bioorg Chem Mol Biol. 6 (2e): 1–6, 2018.

[137] A. Heidari, “Investigation of Bladder Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver, Lung Cancer, Melanoma, Non–Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer and Non–Melanoma Skin Cancer Using Synchrotron Technology for Proton Beam Therapy: An Experimental Biospectroscopic Comparative Studyâ€, Ther Res Skin Dis 1 (1), 2018.

[138] A. Heidari, “Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy and Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Timeâ€, International Journal of Chemistry Papers, 2 (1): 1–12, 2018.

[139] A. Heidari, “Mössbauer Spectroscopy, Mössbauer Emission Spectroscopy and 57Fe Mössbauer Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Acta Scientific Cancer Biology 2.3: 17–20, 2018.

[140] A. Heidari, “Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Timeâ€, Organic & Medicinal Chem IJ. 6 (1): 555676, 2018.

[141] A. Heidari, “Correlation Spectroscopy, Exclusive Correlation Spectroscopy and Total Correlation Spectroscopy Comparative Study on Malignant and Benign Human AIDS–Related Cancers Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Int J Bioanal Biomed. 2 (1): 001–007, 2018.

[142] A. Heidari, “Biomedical Instrumentation and Applications of Biospectroscopic Methods and Techniques in Malignant and Benign Human Cancer Cells and Tissues Studies under Synchrotron Radiation and Anti–Cancer Nano Drugs Deliveryâ€, Am J Nanotechnol Nanomed. 1 (1): 001–009, 2018.

[143] A. Heidari, “Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Ann Biomet Biostat. 1 (1): 1001, 2018.

[144] A. Heidari, “Grazing–Incidence Small–Angle Neutron Scattering (GISANS) and Grazing–Incidence X–Ray Diffraction (GIXD) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron Radiationâ€, Ann Cardiovasc Surg. 1 (2): 1006, 2018.

[145] A. Heidari, “Adsorption Isotherms and Kinetics of Multi–Walled Carbon Nanotubes (MWCNTs), Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs) for Eliminating Carcinoma, Sarcoma, Lymphoma, Leukemia, Germ Cell Tumor and Blastoma Cancer Cells and Tissuesâ€, Clin Med Rev Case Rep 5: 201, 2018.

[146] A. Heidari, “Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Incredible Natural–Abundance Double–Quantum Transfer Experiment (INADEQUATE), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC), Nuclear Overhauser Effect Spectroscopy (NOESY) and Rotating Frame Nuclear Overhauser Effect Spectroscopy (ROESY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Acta Scientific Pharmaceutical Sciences 2.5: 30–35, 2018.

[147] A. Heidari, “Small–Angle X–Ray Scattering (SAXS), Ultra–Small Angle X–Ray Scattering (USAXS), Fluctuation X–Ray Scattering (FXS), Wide–Angle X–Ray Scattering (WAXS), Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS), Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS), Small–Angle Neutron Scattering (SANS), Grazing–Incidence Small–Angle Neutron Scattering (GISANS), X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD), Wide–Angle X–Ray Diffraction (WAXD), Grazing–Incidence X–Ray Diffraction (GIXD) and Energy–Dispersive X–Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Oncol Res Rev, Volume 1 (1): 1–10, 2018.

[148] A. Heidari, “Pump–Probe Spectroscopy and Transient Grating Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Adv Material Sci Engg, Volume 2, Issue 1, Pages 1–7, 2018.

[149] A. Heidari, “Grazing–Incidence Small–Angle X–Ray Scattering (GISAXS) and Grazing–Incidence Wide–Angle X–Ray Scattering (GIWAXS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Insights Pharmacol Pharm Sci 1 (1): 1–8, 2018.

[150] A. Heidari, “Acoustic Spectroscopy, Acoustic Resonance Spectroscopy and Auger Spectroscopy Comparative Study on Anti–Cancer Nano Drugs Delivery in Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Nanosci Technol 5 (1): 1–9, 2018.

[151] A. Heidari, “Niobium, Technetium, Ruthenium, Rhodium, Hafnium, Rhenium, Osmium and Iridium Ions Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiationsâ€, Nanomed Nanotechnol, 3 (2): 000138, 2018.

[152] A. Heidari, “Homonuclear Correlation Experiments such as Homonuclear Single–Quantum Correlation Spectroscopy (HSQC), Homonuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Homonuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, Austin J Proteomics Bioinform & Genomics. 5 (1): 1024, 2018.

[153] A. Heidari, “Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy and Nuclear Resonance Vibrational Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Timeâ€, J Appl Biotechnol Bioeng. 5 (3): 142‒148, 2018.

[154] A. Heidari, “Time–Dependent Vibrational Spectral Analysis of Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiationâ€, J Cancer Oncol, 2 (2): 000124, 2018.

[155] A. Heidari, “Palauamine and Olympiadane Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiationsâ€, Arc Org Inorg Chem Sci 3 (1), 2018.

[156] R. Gobato, A. Heidari, “Infrared Spectrum and Sites of Action of Sanguinarine by Molecular Mechanics and ab initio Methodsâ€, International Journal of Atmospheric and Oceanic Sciences. Vol. 2, No. 1, pp. 1–9, 2018.

[157] A. Heidari, “Angelic Acid, Diabolic Acids, Draculin and Miraculin Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment Under Synchrotron and Synchrocyclotron Radiationsâ€, Med & Analy Chem Int J, 2 (1): 000111, 2018.

[158] A. Heidari, “Gamma Linolenic Methyl Ester, 5–Heptadeca–5,8,11–Trienyl 1,3,4–Oxadiazole–2–Thiol, Sulphoquinovosyl Diacyl Glycerol, Ruscogenin, Nocturnoside B, Protodioscine B, Parquisoside–B, Leiocarposide, Narangenin, 7–Methoxy Hespertin, Lupeol, Rosemariquinone, Rosmanol and Rosemadiol Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiationsâ€, Int J Pharma Anal Acta, 2 (1): 007–014, 2018.

[159] A. Heidari, “Fourier Transform Infrared (FTIR) Spectroscopy, Attenuated Total Reflectance Fourier Transform Infrared (ATR–FTIR) Spectroscopy, Micro–Attenuated Total Reflectance Fourier Transform Infrared (Micro–ATR–FTIR) Spectroscopy, Macro–Attenuated Total Reflectance Fourier Transform Infrared (Macro–ATR–FTIR) Spectroscopy, Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy, Non–Linear Two–Dimensional Infrared Spectroscopy, Atomic Force Microscopy Based Infrared (AFM–IR) Spectroscopy, Infrared Photodissociation Spectroscopy, Infrared Correlation Table Spectroscopy, Near–Infrared Spectroscopy (NIRS), Mid–Infrared Spectroscopy (MIRS), Nuclear Resonance Vibrational Spectroscopy, Thermal Infrared Spectroscopy and Photothermal Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Timeâ€, Glob Imaging Insights, Volume 3 (2): 1–14, 2018.

[160] A. Heidari, “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiationsâ€, Chronicle of Medicine and Surgery 2.3: 144–156, 2018.

[161] A. Heidari, “Tetrakis [3, 5–bis (Trifluoromethyl) Phenyl] Borate (BARF)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Moleculesâ€, Medical Research and Clinical Case Reports 2.1: 113–126, 2018.

[162] A. Heidari, “Sydnone, Münchnone, Montréalone, Mogone, Montelukast, Quebecol and Palau’amine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Moleculesâ€, Sur Cas Stud Op Acc J. 1 (3), 2018.

[163] A. Heidari, “Fornacite, Orotic Acid, Rhamnetin, Sodium Ethyl Xanthate (SEX) and Spermine (Spermidine or Polyamine) Nanomolecules Incorporation into the Nanopolymeric Matrix (NPM)â€, International Journal of Biochemistry and Biomolecules, Vol. 4: Issue 1, Pages 1–19, 2018.

[164] A. Heidari, R. Gobato, “Putrescine, Cadaverine, Spermine and Spermidine–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Moleculesâ€, Parana Journal of Science and Education (PJSE)–v.4, n.5, (1–14) July 1, 2018.

[165] A. Heidari, “Cadaverine (1,5–Pentanediamine or Pentamethylenediamine), Diethyl Azodicarboxylate (DEAD or DEADCAT) and Putrescine (Tetramethylenediamine) Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiationsâ€, Hiv and Sexual Health Open Access Open Journal. 1 (1): 4–11, 2018.

[166] A. Heidari, “Improving the Performance of Nano–Endofullerenes in Polyaniline Nanostructure–Based Biosensors by Covering Californium Colloidal Nanoparticles with Multi–Walled Carbon Nanotubesâ€, Journal of Advances in Nanomaterials, Vol. 3, No. 1, Pages 1–28, 2018.

[167] R. Gobato, A. Heidari, “Molecular Mechanics and Quantum Chemical Study on Sites of Action of Sanguinarine Using Vibrational Spectroscopy Based on Molecular Mechanics and Quantum Chemical Calculationsâ€, Malaysian Journal of Chemistry, Vol. 20 (1), 1–23, 2018.

[168] A. Heidari, “Vibrational Biospectroscopic Studies on Anti–cancer Nanopharmaceuticals (Part I)â€, Malaysian Journal of Chemistry, Vol. 20 (1), 33–73, 2018.

[169] A. Heidari, “Vibrational Biospectroscopic Studies on Anti–cancer Nanopharmaceuticals (Part II)â€, Malaysian Journal of Chemistry, Vol. 20 (1), 74–117, 2018.

[170] A. Heidari, “Uranocene (U(C8H8)2) and Bis(Cyclooctatetraene)Iron (Fe(C8H8)2 or Fe(COT)2)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Moleculesâ€, Chemistry Reports, Vol. 1, Iss. 2, Pages 1–16, 2018.

[171] A. Heidari, “Biomedical Systematic and Emerging Technological Study on Human Malignant and Benign Cancer Cells and Tissues Biospectroscopic Analysis under Synchrotron Radiationâ€, Glob Imaging Insights, Volume 3 (3): 1–7, 2018.

[172] A. Heidari, “Deep–Level Transient Spectroscopy and X–Ray Photoelectron Spectroscopy (XPS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Res Dev Material Sci. 7(2). RDMS.000659, 2018.

[173] A. Heidari, “C70–Carboxyfullerenes Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiationsâ€, Glob Imaging Insights, Volume 3 (3): 1–7, 2018.

[174] A. Heidari, “The Effect of Temperature on Cadmium Oxide (CdO) Nanoparticles Produced by Synchrotron Radiation in the Human Cancer Cells, Tissues and Tumorsâ€, International Journal of Advanced Chemistry, 6 (2) 140–156, 2018.

[175] A. Heidari, “A Clinical and Molecular Pathology Investigation of Correlation Spectroscopy (COSY), Exclusive Correlation Spectroscopy (ECOSY), Total Correlation Spectroscopy (TOCSY), Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells, Tissues and Tumors under Synchrotron and Synchrocyclotron Radiations Using Cyclotron versus Synchrotron, Synchrocyclotron and the Large Hadron Collider (LHC) for Delivery of Proton and Helium Ion (Charged Particle) Beams for Oncology Radiotherapyâ€, European Journal of Advances in Engineering and Technology, 5 (7): 414–426, 2018.

[176] A. Heidari, “Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiationsâ€, J Oncol Res; 1 (1): 1–20, 2018.

[177] A. Heidari, “Use of Molecular Enzymes in the Treatment of Chronic Disordersâ€, Canc Oncol Open Access J. 1 (1): 12–15, 2018.

[178] A. Heidari, “Vibrational Biospectroscopic Study and Chemical Structure Analysis of Unsaturated Polyamides Nanoparticles as Anti–Cancer Polymeric Nanomedicines Using Synchrotron Radiationâ€, International Journal of Advanced Chemistry, 6 (2) 167–189, 2018.

[179] A. Heidari, “Adamantane, Irene, Naftazone and Pyridine–Enhanced Precatalyst Preparation Stabilization and Initiation (PEPPSI) Nano Moleculesâ€, Madridge J Nov Drug Res. 2 (1): 61–67, 2018.

[180] A. Heidari, “Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Madridge J Nov Drug Res, 2 (1): 68–74, 2018.

[181] A. Heidari, R. Gobato, “A Novel Approach to Reduce Toxicities and to Improve Bioavailabilities of DNA/RNA of Human Cancer Cells–Containing Cocaine (Coke), Lysergide (Lysergic Acid Diethyl Amide or LSD), Δâ¹â€“Tetrahydrocannabinol (THC) [(–)–trans–Δâ¹â€“Tetrahydrocannabinol], Theobromine (Xantheose), Caffeine, Aspartame (APM) (NutraSweet) and Zidovudine (ZDV) [Azidothymidine (AZT)] as Anti–Cancer Nano Drugs by Coassembly of Dual Anti–Cancer Nano Drugs to Inhibit DNA/RNA of Human Cancer Cells Drug Resistanceâ€, Parana Journal of Science and Education, v. 4, n. 6, pp. 1–17, 2018.

[182] A. Heidari, R. Gobato, “Ultraviolet Photoelectron Spectroscopy (UPS) and Ultraviolet–Visible (UV–Vis) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiationâ€, Parana Journal of Science and Education, v. 4, n. 6, pp. 18–33, 2018.

[183] R. Gobato, A. Heidari, A. Mitra, “The Creation of C13H20BeLi2SeSi. The Proposal of a Bio–Inorganic Molecule, Using Ab Initio Methods for the Genesis of a Nano Membraneâ€, Arc Org Inorg Chem Sci 3 (4). AOICS.MS.ID.000167, 2018.

[184] R. Gobato, A. Heidari, “Using the Quantum Chemistry for Genesis of a Nano Biomembrane with a Combination of the Elements Be, Li, Se, Si, C and Hâ€, J Nanomed Res.7 (4): 241‒252, 2018.

[185] A. Heidari, “Bastadins and Bastaranes–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Moleculesâ€, Glob Imaging Insights, Volume 3 (4): 1–7, 2018.

[186] A. Heidari, “Fucitol, Pterodactyladiene, DEAD or DEADCAT (DiEthyl AzoDiCArboxylaTe), Skatole, the NanoPutians, Thebacon, Pikachurin, Tie Fighter, Spermidine and Mirasorvone Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiationsâ€, Glob Imaging Insights, Volume 3 (4): 1–8, 2018.

[187] E. Dadvar, A. Heidari, “A Review on Separation Techniques of Graphene Oxide (GO)/Base on Hybrid Polymer Membranes for Eradication of Dyes and Oil Compounds: Recent Progress in Graphene Oxide (GO)/Base on Polymer Membranes–Related Nanotechnologiesâ€, Clin Med Rev Case Rep 5: 228, 2018.

[188] A. Heidari, R. Gobato, “First–Time Simulation of Deoxyuridine Monophosphate (dUMP) (Deoxyuridylic Acid or Deoxyuridylate) and Vomitoxin (Deoxynivalenol (DON)) ((3α,7α)–3,7,15–Trihydroxy–12,13–Epoxytrichothec–9–En–8–One)–Enhanced Precatalyst Preparation Stabilization and Initiation

Downloads

Published

2021-11-04

Issue

Section

Articles